Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GZPHF)
2.88
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Guangzhou Baiyunshan Pharmaceutical Holdings Shareholders Equity (Quarterly): 5.182B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.182B |
December 31, 2023 | 4.926B |
September 30, 2023 | 4.750B |
June 30, 2023 | 4.644B |
June 30, 2023 | 4.644B |
March 31, 2023 | 4.936B |
December 31, 2022 | 4.648B |
September 30, 2022 | 4.410B |
June 30, 2022 | 4.557B |
June 30, 2022 | 4.557B |
March 31, 2022 | 4.855B |
December 31, 2021 | 4.559B |
September 30, 2021 | 4.416B |
June 30, 2021 | 4.295B |
June 30, 2021 | 4.295B |
March 31, 2021 | 4.219B |
December 31, 2020 | 4.002B |
September 30, 2020 | 3.790B |
June 30, 2020 | 3.524B |
June 30, 2020 | 3.524B |
March 31, 2020 | 3.569B |
December 31, 2019 | 3.457B |
September 30, 2019 | 3.391B |
June 30, 2019 | 3.418B |
June 30, 2019 | 3.418B |
Date | Value |
---|---|
March 31, 2019 | 3.440B |
December 31, 2018 | 3.152B |
September 30, 2018 | 3.153B |
June 30, 2018 | 3.149B |
June 30, 2018 | 3.149B |
March 31, 2018 | 3.145B |
December 31, 2017 | 2.890B |
September 30, 2017 | 2.757B |
June 30, 2017 | 2.659B |
June 30, 2017 | 2.659B |
March 31, 2017 | 2.588B |
December 31, 2016 | 2.497B |
September 30, 2016 | 2.606B |
June 30, 2016 | 1.400B |
June 30, 2016 | 1.400B |
March 31, 2016 | 1.370B |
December 31, 2015 | 1.302B |
September 30, 2015 | 1.276B |
June 30, 2015 | 1.310B |
June 30, 2015 | 1.310B |
March 31, 2015 | 1.305B |
December 31, 2014 | 1.242B |
September 30, 2014 | 1.202B |
June 30, 2014 | 1.158B |
June 30, 2014 | 1.158B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.391B
Minimum
Sep 2019
5.182B
Maximum
Mar 2024
4.240B
Average
4.410B
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Sino Biopharmaceutical Ltd | 4.299B |
HUTCHMED (China) Ltd | 730.54M |
Pharmaron Beijing Co Ltd | 1.595B |
Regencell Bioscience Holdings Ltd | 10.20M |
Prenetics Global Ltd | 199.44M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.06B |
Total Liabilities (Quarterly) | 5.620B |
Debt to Equity Ratio | 0.3591 |
Current Ratio | 1.640 |
Net Debt Paydown Yield | -1.21% |